D-氨基酸氧化酶(DAO)單克隆抗體
Monoclonal Antibody to D-Amino Acid Oxidase (DAO)
DAMOX
- 編號MAJ298Hu21
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)-
- Ig亞型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 -
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度1mg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 666 ¥ 1554 ¥ 2220 ¥ 5550 ¥ 22200
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對DAO的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別DAO。
用法
免疫印跡：0.2-2μg/mL;1:500-5000
免疫組織化學(xué)：5-20μg/mL;1:50-200
免疫細胞化學(xué)：5-20μg/mL;1:50-200
最佳稀釋倍數(shù)最終由用戶決定。
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPJ298Hu01 | D-氨基酸氧化酶(DAO)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAJ298Hu01 | D-氨基酸氧化酶(DAO)多克隆抗體 | WB; IHC; ICC; IP. |
| MAJ298Hu21 | D-氨基酸氧化酶(DAO)單克隆抗體 | WB; IHC; ICC; IP. |
| SEJ298Hu | D-氨基酸氧化酶(DAO)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCJ298Hu | D-氨基酸氧化酶(DAO)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMJ298Hu | D-氨基酸氧化酶(DAO)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| 無 | Differential regulation of D-amino acid oxidase (DAO) mRNA and protein expression in human post-mortem brain [Dam: Jcr:3107E495-Ef68-4692-85Be-D43D9F3F84Ff] |
| 不確定雜志名 | Age span expression of schizophrenia susceptibility genes D-amino acid oxidase (DAO) and DAO activator (DAOA) in human post-mortem brain [dam:jcr:c3394762-a692-4fbd-8a37-7da14f429996] |
| Frontiers in Neuroanatomy | Expression of D-Amino Acid Oxidase (DAO/DAAO) and D-Amino Acid Oxidase Activator (DAOA/G72) during Development and Aging in the Human Post-mortem Brain. [pubmed:28428746] |
| BMC?gastroenterology | Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study [Pubmed: 30400824] |
| Journal of Gastroenterology | Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice [Pubmed: 30519748] |
| Phytotherapy?Research | Effect of a chamomile extract in protecting against radiation‐induced intestinal mucositis [Pubmed: 30632234] |
| Biological & Pharmaceutical Bulletin | Role of Aquaporin-3 in Intestinal Injury Induced by Sepsis [Pubmed: 31582652] |
| Int Immunopharmacol | Hydrogen attenuates radiation-induced intestinal damage by reducing oxidative stress and inflammatory response [Pubmed: 32361189] |
| european journal of clinical nutrition? | Effect of Lactobacillus casei on lipid metabolism and intestinal microflora in patients with alcoholic liver injury [33514869] |
| Nutrients | The Relationship between Low Serum Vitamin D Levels and Altered Intestinal Barrier Function in Patients with IBS Diarrhoea Undergoing a Long-Term Low-FODMAP [33801020] |
| J Cell Mol Med | The |á2AR/Caveolin?\1/p38MAPK/NF?\|êB axis explains dexmedetomidine protection against lung injury following intestinal ischaemia?\reperfusion [34114328] |
| BMC Gastroenterol | Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity [34022802] |
| Nutrients | Psychological and Gastrointestinal Symptoms of Patients with Irritable Bowel Syndrome Undergoing a Low-FODMAP Diet: The Role of the Intestinal Barrier [34371976] |
| Int J Neuropsychopharmacol | Blood D-amino acid oxidase (DAO) levels increased with cognitive decline among people with mild cognitive impairment (MCI): a two-year prospective study [Pubmed:35430632] |
留言咨詢
